← Back to Lincoln Pharmaceuticals Ltd Overview
📊Financials📈PE Ratio🥧Shareholding💰Dividend📋Quarterly⚖️Balance Sheet💹P&L🌊Cash Flow
LINCOLNPharmaceuticals

Lincoln Pharmaceuticals Ltd — Financial Ratios & Key Metrics

₹564.95
-2.30%
P/E Ratio12.68xIndustry: 31.77x
ROE12.82%Return on equity
ROCE17.28%Return on capital
Debt/Equity0.00Debt free ✓
💎

Valuation & Profitability

P/E Ratio
12.68x
Industry Average P/E
31.77x
Dividend Yield
0.36%
Market Cap
₹1.01K (Cr)
Sales Growth 5Y
10.03%
Profit Growth 5Y
9.50%
EPS Growth 5Y
9.47%
OPM 5Y Avg
18.17%
📉

Price Returns

1 Month
-4.35%
3 Months
-8.87%
6 Months
-7.54%
1 Year
-19.73%
52W Low
₹440
Current
₹565
52W High
₹677
53% of 52-week range — Mid range
🔬

Technical Indicators

37RSI 14
Neutral
Momentum is balanced — neither overbought nor oversold.
SMA 50
₹556
▲ Price above SMA 50 — Bullish
SMA 200
₹539
▲ Long-term uptrend
Volume Signal
23% of avg
Below average volume — low conviction

Technical indicators are for educational purposes only. Not investment advice.

More on Lincoln Pharmaceuticals Ltd

OverviewFinancialsPE HistoryShareholdingQuarterlyBalance SheetP&LCash FlowPharmaceuticals StocksScreener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.